{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:52:13Z","timestamp":1791071533513,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"DOI":"10.1038\/s41416-026-03625-5","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:45:46Z","timestamp":1791024346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From initial complete response to recurrence: ENPP1 mutation drives cisplatin resistance through STING\/NF-\u03baB\/IL-6 axis in hypopharyngeal squamous cell carcinoma"],"prefix":"10.1038","author":[{"given":"Chunyan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuncun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-9675","authenticated-orcid":false,"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5455-9454","authenticated-orcid":false,"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2393-7897","authenticated-orcid":false,"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"3625_CR1","doi-asserted-by":"publisher","first-page":"1109417","DOI":"10.3389\/fonc.2023.1109417","volume":"13","author":"TY Lin","year":"2023","unstructured":"Lin TY, Lee TL, Hsu YB, Tai SK, Wang LW, Yang MH, et al. Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma. Front Oncol. 2023;13:1109417. https:\/\/doi.org\/10.3389\/fonc.2023.1109417.","journal-title":"Front Oncol"},{"key":"3625_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.oraloncology.2018.09.025","volume":"86","author":"JC Garneau","year":"2018","unstructured":"Garneau JC, Bakst RL, Miles BA. Hypopharyngeal cancer: A state of the art review. Oral Oncol. 2018;86:244\u201350. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.09.025.","journal-title":"Oral Oncol"},{"key":"3625_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/JCMA.0000000000001121","volume":"87","author":"CF Chang","year":"2024","unstructured":"Chang CF, Wang LW, Yang MH, Chu PY. Induction chemotherapy followed by transoral laser microsurgery with or without adjuvant therapy for advanced hypopharyngeal cancer patients: A preliminary result. J Chin Med Assoc. 2024;87:803\u20138. https:\/\/doi.org\/10.1097\/JCMA.0000000000001121.","journal-title":"J Chin Med Assoc"},{"key":"3625_CR4","doi-asserted-by":"publisher","unstructured":"Karabajakian A, Gau M, Reverdy T, Neidhardt EM, Fayette J. Induction chemotherapy in head and neck squamous cell carcinoma: a question of belief. Cancers, 2018:11. https:\/\/doi.org\/10.3390\/cancers11010015.","DOI":"10.3390\/cancers11010015"},{"key":"3625_CR5","doi-asserted-by":"publisher","unstructured":"Yu W, Chen Y, Putluri N, Coarfa C, Robertson MJ, Putluri V et al. Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress. Cancers, 2020:12. https:\/\/doi.org\/10.3390\/cancers12061670.","DOI":"10.3390\/cancers12061670"},{"key":"3625_CR6","doi-asserted-by":"publisher","first-page":"85326","DOI":"10.18632\/oncotarget.19674","volume":"8","author":"P Wu","year":"2017","unstructured":"Wu P, Wu H, Tang Y, Luo S, Fang X, Xie C, et al. Whole-exome sequencing reveals novel mutations and epigenetic regulation in hypopharyngeal carcinoma. Oncotarget. 2017;8:85326\u201340. https:\/\/doi.org\/10.18632\/oncotarget.19674.","journal-title":"Oncotarget"},{"key":"3625_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27273-w","volume":"13","author":"J Yao","year":"2023","unstructured":"Yao J, Ding Y, Liu X, Huang J, Zhang M, Zhang Y, et al. Application value of whole exome sequencing in screening and identifying novel mutations of hypopharyngeal cancer. Sci Rep. 2023;13:107. https:\/\/doi.org\/10.1038\/s41598-022-27273-w.","journal-title":"Sci Rep"},{"key":"3625_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tig.2018.05.007","volume":"34","author":"KL Pogrebniak","year":"2018","unstructured":"Pogrebniak KL, Curtis C. Harnessing tumor evolution to circumvent resistance. Trends Genet. 2018;34:639\u201351. https:\/\/doi.org\/10.1016\/j.tig.2018.05.007.","journal-title":"Trends Genet"},{"key":"3625_CR9","doi-asserted-by":"publisher","first-page":"e2313693120.","DOI":"10.1073\/pnas.2313693120","volume":"120","author":"S Wang","year":"2023","unstructured":"Wang S, B\u00f6hnert V, Joseph AJ, Sudaryo V, Skariah G, Swinderman JT, et al. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer. Proc Natl Acad Sci USA. 2023;120:e2313693120. https:\/\/doi.org\/10.1073\/pnas.2313693120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3625_CR10","doi-asserted-by":"publisher","first-page":"Unit7.20","DOI":"10.1002\/0471142905.hg0720s76","volume":"7","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;7:Unit7.20 https:\/\/doi.org\/10.1002\/0471142905.hg0720s76.","journal-title":"Curr Protoc Hum Genet"},{"key":"3625_CR11","doi-asserted-by":"publisher","first-page":"1001173","DOI":"10.3389\/fimmu.2022.1001173","volume":"13","author":"X Xu","year":"2022","unstructured":"Xu X, Wang Y, Bai Y, Lu J, Guo Y, Wang X, et al. Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma. Front Immunol. 2022;13:1001173 https:\/\/doi.org\/10.3389\/fimmu.2022.1001173.","journal-title":"Front Immunol"},{"key":"3625_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.05.017","volume":"517","author":"Q Huang","year":"2021","unstructured":"Huang Q, Hsueh CY, Shen YJ, Guo Y, Huang JM, Zhang YF, et al. Small extracellular vesicle-packaged TGF\u03b21 promotes the reprogramming of normal fibroblasts into cancer-associated fibroblasts by regulating fibronectin in head and neck squamous cell carcinoma. Cancer Lett. 2021;517:1\u201313. https:\/\/doi.org\/10.1016\/j.canlet.2021.05.017.","journal-title":"Cancer Lett"},{"key":"3625_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s12276-023-00984-4","volume":"55","author":"HC Wang","year":"2023","unstructured":"Wang HC, Moi SH, Chan LP, Wu CC, Du JS, Liu PL, et al. The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy. Exp Mol Med. 2023;55:926\u201338. https:\/\/doi.org\/10.1038\/s12276-023-00984-4.","journal-title":"Exp Mol Med"},{"key":"3625_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejca.2019.04.015","volume":"116","author":"T Eder","year":"2019","unstructured":"Eder T, Hess AK, Konschak R, Stromberger C, J\u00f6hrens K, Fleischer V, et al. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. Eur J Cancer. 2019;116:67\u201376. https:\/\/doi.org\/10.1016\/j.ejca.2019.04.015.","journal-title":"Eur J Cancer"},{"key":"3625_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38672-x","volume":"9","author":"C Chandrasekhar","year":"2019","unstructured":"Chandrasekhar C, Kumar PS, Sarma PVGK. Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. Sci Rep. 2019;9:2412. https:\/\/doi.org\/10.1038\/s41598-019-38672-x.","journal-title":"Sci Rep"},{"key":"3625_CR16","doi-asserted-by":"publisher","first-page":"16876","DOI":"10.1073\/pnas.1208017109","volume":"109","author":"K Kato","year":"2012","unstructured":"Kato K, Nishimasu H, Okudaira S, Mihara E, Ishitani R, Takagi J, et al. Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling. Proc Natl Acad Sci USA. 2012;109:16876\u201381. https:\/\/doi.org\/10.1073\/pnas.1208017109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3625_CR17","doi-asserted-by":"publisher","first-page":"2308131","DOI":"10.1002\/advs.202308131","volume":"11","author":"Y An","year":"2024","unstructured":"An Y, Zhu J, Xie Q, Feng J, Gong Y, Fan Q, et al. Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling. Adv Sci. 2024;11:2308131 https:\/\/doi.org\/10.1002\/advs.202308131.","journal-title":"Adv Sci"},{"key":"3625_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/lary.24915","volume":"125","author":"JR Newman","year":"2015","unstructured":"Newman JR, Connolly TM, Illing EA, Kilgore ML, Locher JL, Carroll WR. Survival trends in hypopharyngeal cancer: a population-based review. Laryngoscope. 2015;125:624\u20139. https:\/\/doi.org\/10.1002\/lary.24915.","journal-title":"Laryngoscope"},{"key":"3625_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/annonc\/mdy102","volume":"29","author":"RI Haddad","year":"2018","unstructured":"Haddad RI, Posner M, Hitt R, Cohen EEW, Schulten J, Lefebvre JL, et al. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol. 2018;29:1130\u201340. https:\/\/doi.org\/10.1093\/annonc\/mdy102.","journal-title":"Ann Oncol"},{"key":"3625_CR20","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa071028.","journal-title":"N Engl J Med"},{"key":"3625_CR21","doi-asserted-by":"publisher","unstructured":"Gauss C, Stone LD, Ghafouri M, Quan D, Johnson J, Fribley AM et al. Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas. Cells, 2024, 13. https:\/\/doi.org\/10.3390\/cells13121018.","DOI":"10.3390\/cells13121018"},{"key":"3625_CR22","doi-asserted-by":"publisher","first-page":"640392.","DOI":"10.3389\/fonc.2021.640392","volume":"11","author":"Y Kanno","year":"2021","unstructured":"Kanno Y, Chen CY, Lee HL, Chiou JF, Chen YJ. Molecular mechanisms of chemotherapy resistance in head and neck cancers. Front Oncol. 2021;11:640392. https:\/\/doi.org\/10.3389\/fonc.2021.640392.","journal-title":"Front Oncol"},{"key":"3625_CR23","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.1206923","volume":"333","author":"N Agrawal","year":"2011","unstructured":"Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154\u20137. https:\/\/doi.org\/10.1126\/science.1206923.","journal-title":"Science"},{"key":"3625_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1158\/2159-8290.CD-21-0932","volume":"12","author":"Ruiz-Fern\u00e1ndez De C\u00f3rdoba","year":"2022","unstructured":"Ruiz-Fern\u00e1ndez De C\u00f3rdoba, Moreno B, Valencia H, Perurena K, Ruedas P N, Walle T, et al. Tumor ENPP1 (CD203a)\/Haptoglobin axis exploits myeloid-derived suppressor cells to promote post-radiotherapy local recurrence in breast cancer. Cancer Discov. 2022;12:1356\u201377. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0932.","journal-title":"Cancer Discov"},{"key":"3625_CR25","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1158\/2326-6066.CIR-22-0140","volume":"11","author":"SS Attalla","year":"2023","unstructured":"Attalla SS, Boucher J, Proud H, Taifour T, Zuo D, Sanguin-Gendreau V, et al. HER2\u039416 engages ENPP1 to promote an immune-cold microenvironment in breast cancer. Cancer Immunol Res. 2023;11:1184\u2013202. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0140.","journal-title":"Cancer Immunol Res"},{"key":"3625_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/neuonc\/noae169","volume":"27","author":"L Santos","year":"2024","unstructured":"Santos L, Tomatis F, Ferreira HRS, Almeida SFF, Ciputra E, Sereno J, et al. ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in HER2-positive breast cancer. Neuro-Oncol. 2024;27:167\u201383.","journal-title":"Neuro-Oncol"},{"key":"3625_CR27","doi-asserted-by":"publisher","first-page":"e23420.","DOI":"10.1096\/fj.202301835R","volume":"38","author":"C Ma","year":"2024","unstructured":"Ma C, Zhao J, Zhou L, Jia C, Shi Y, Li X, et al. Targeting ENPP1 depletion may be a promising therapeutic strategy for treating oral squamous cell carcinoma via cytotoxic autophagy-related apoptosis. FASEB J. 2024;38:e23420. https:\/\/doi.org\/10.1096\/fj.202301835R.","journal-title":"FASEB J"},{"key":"3625_CR28","doi-asserted-by":"publisher","first-page":"e0245733.","DOI":"10.1371\/journal.pone.0245733","volume":"16","author":"H Wang","year":"2021","unstructured":"Wang H, Ye F, Zhou C, Cheng Q, Chen H. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target. PLoS ONE. 2021;16:e0245733. https:\/\/doi.org\/10.1371\/journal.pone.0245733.","journal-title":"PLoS ONE"},{"key":"3625_CR29","first-page":"134","volume":"9","author":"M Hu","year":"2019","unstructured":"Hu M, Guo W, Liao Y, Xu D, Sun B, Song H, et al. Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features. Am J Cancer Res. 2019;9:134\u201344.","journal-title":"Am J Cancer Res"},{"key":"3625_CR30","doi-asserted-by":"publisher","first-page":"e2119189119.","DOI":"10.1073\/pnas.2119189119","volume":"119","author":"JA Carozza","year":"2022","unstructured":"Carozza JA, Cordova AF, Brown JA, AlSaif Y, B\u00f6hnert V, Cao X, et al. ENPP1\u2019s regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling. Proc Natl Acad Sci USA. 2022;119:e2119189119. https:\/\/doi.org\/10.1073\/pnas.2119189119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3625_CR31","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/2159-8290.CD-20-0387","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Duran MA, Dhanota N, Chatila WK, Bettigole SE, Kwon J, et al. Metastasis and immune evasion from extracellular cGAMP hydrolysis. Cancer Discov. 2021;11:1212\u201327. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0387.","journal-title":"Cancer Discov"},{"key":"3625_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-biochem-040320-101629","volume":"91","author":"C Ritchie","year":"2022","unstructured":"Ritchie C, Carozza JA, Li L. Biochemistry, cell biology, and pathophysiology of the innate immune cGAS\u2013cGAMP\u2013STING pathway. Annu Rev Biochem. 2022;91:599\u2013628. https:\/\/doi.org\/10.1146\/annurev-biochem-040320-101629.","journal-title":"Annu Rev Biochem"},{"key":"3625_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.celrep.2019.03.098","volume":"27","author":"CC de Oliveira Mann","year":"2019","unstructured":"de Oliveira Mann CC, Orzalli MH, King DS, Kagan JC, Lee ASY, Kranzusch PJ. Modular architecture of the STING C-terminal tail allows interferon and NF-\u03baB signaling adaptation. Cell Rep. 2019;27:1165\u201375.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.098.","journal-title":"Cell Rep"},{"key":"3625_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu J, Dobbs N, Yang K, Yan N. Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion. Immunity. 2020;53:115\u201326.e5. https:\/\/doi.org\/10.1016\/j.immuni.2020.06.009.","journal-title":"Immunity"},{"key":"3625_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.devcel.2025.12.007","volume":"61","author":"ZD Zhang","year":"2026","unstructured":"Zhang ZD, Lin YL, Zhang HY, Zuo C, Zhu ZL, Wang XY, et al. MITA\/STING-driven CD38 induction in Siglec-Flow macrophages promotes regulatory T cell survival and non-small cell lung cancer progression. Dev Cell. 2026;61:638\u201354.e8. https:\/\/doi.org\/10.1016\/j.devcel.2025.12.007.","journal-title":"Dev Cell"},{"key":"3625_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","volume":"43","author":"H Song","year":"2025","unstructured":"Song H, Chen L, Pan X, Shen Y, Ye M, Wang G, et al. Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy. Cancer Cell. 2025;43:503\u201318.e10. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.014.","journal-title":"Cancer Cell"},{"key":"3625_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","volume":"607","author":"C Hong","year":"2022","unstructured":"Hong C, Schubert M, Tijhuis AE, Requesens M, Roorda M, Van Den Brink A, et al. cGAS\u2013STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature. 2022;607:366\u201373. https:\/\/doi.org\/10.1038\/s41586-022-04847-2.","journal-title":"Nature"},{"key":"3625_CR38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10495-022-01763-8","volume":"27","author":"H Vasiyani","year":"2022","unstructured":"Vasiyani H, Mane M, Rana K, Shinde A, Roy M, Singh J, et al. DNA damage induces STING-mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients. Apoptosis. 2022;27:961\u201378. https:\/\/doi.org\/10.1007\/s10495-022-01763-8.","journal-title":"Apoptosis"},{"key":"3625_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature10760","volume":"481","author":"CJ Lord","year":"2012","unstructured":"Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481:287\u201394. https:\/\/doi.org\/10.1038\/nature10760.","journal-title":"Nature"},{"key":"3625_CR40","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-22-2747","volume":"29","author":"AA Osman","year":"2023","unstructured":"Osman AA, Arslan E, Bartels M, Michikawa C, Lindemann A, Tomczak K, et al. Dysregulation and epigenetic reprogramming of NRF2 signaling axis promote acquisition of Cisplatin resistance and metastasis in head and neck squamous cell carcinoma. Clin Cancer Res. 2023;29:1344\u201359. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-2747.","journal-title":"Clin Cancer Res"},{"key":"3625_CR41","doi-asserted-by":"publisher","unstructured":"de Bakker T, Maes A, Dragan T, Martinive P, Penninckx S, Van Gestel D. Strategies to overcome intrinsic and acquired resistance to chemoradiotherapy in head and neck cancer. Cells, 2024:14. https:\/\/doi.org\/10.3390\/cells14010018.","DOI":"10.3390\/cells14010018"},{"key":"3625_CR42","doi-asserted-by":"publisher","first-page":"102308.","DOI":"10.1016\/j.tranon.2025.102308","volume":"53","author":"AS Becker","year":"2025","unstructured":"Becker AS, Klauk F, Freitag T, Str\u00fcder DF, Schneider B, Zimpfer A, et al. Inhibition of platin-induced BCL2 increase overcomes chemoresistance in squamous cell carcinoma of the head and neck through resensitization to cell death. Transl Oncol. 2025;53:102308. https:\/\/doi.org\/10.1016\/j.tranon.2025.102308.","journal-title":"Transl Oncol"},{"key":"3625_CR43","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41388-026-03725-9","volume":"45","author":"E Jeong","year":"2026","unstructured":"Jeong E, Kim HL, Park S, Jang S, Ku J, Kim H, et al. HERC1 oncogene enhances stemness and tumorigenic potential in CD44(+)-derived organoids of head and neck squamous cell carcinoma through IL-6\/STAT3 signaling. Oncogene. 2026;45:1840\u201355. https:\/\/doi.org\/10.1038\/s41388-026-03725-9.","journal-title":"Oncogene"},{"key":"3625_CR44","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-19-1846","volume":"80","author":"F Nazari","year":"2020","unstructured":"Nazari F, Oklejas AE, N\u00f6r JE, Pearson AT, Jackson TL. In silico models accurately predict in vivo response for IL6 blockade in head and neck cancer. Cancer Res. 2020;80:1451\u201360. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1846.","journal-title":"Cancer Res"},{"key":"3625_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.abc6622","volume":"369","author":"TF Gajewski","year":"2020","unstructured":"Gajewski TF, Higgs EF. Immunotherapy with a sting. Science. 2020;369:921\u20132. https:\/\/doi.org\/10.1126\/science.abc6622.","journal-title":"Science"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03625-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03625-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03625-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:03:21Z","timestamp":1791068601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03625-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":45,"alternative-id":["3625"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03625-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The current study was approved by the Ethics Committee of the Eye & ENT Hospital of Fudan University and was performed in strict accordance with the Declaration of Helsinki. All participants signed an informed consent form.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}